Abstract:The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

Preparation and Characterization of Temozolomide-Loaded Gels

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

Degradable and Thermosensitive Microgels Synthesized Via Simultaneous Quaternization and Siloxane Condensation

Preparation, Characterization and Degradation Characteristics of Polyanhydrides Containing Poly(Ethylene Glycol)

Preparation of transferrin-targeted temozolomide nano-micelles and their anti-glioma effect

Temozolomide nano-in-nanofiber delivery system with sustained release and enhanced cellular uptake by U87MG cells

Preparation of Temozolomide Nano SustainedRelease Microsphere Material and Its Application in Treatment of Glioma

Preparation of temozolomide-loaded polybutylcyanoacrylate nanoparticles

Poly(N-vinylpyrrolidinone) Microgels: Preparation, Biocompatibility, and Potential Application As Drug Carriers.

Thermosensitive hydrogel based on poly(ether-ester anhydride) nanoparticle as drug delivery system: preparation, characterization and biocompatibility.

Enhancement of Temozolomide Stability and Anticancer Efficacy by Loading in Monopalmitolein-Based Cubic Phase Nanoparticles

Synthesis, Characterization and Biocompatibility of Poly(2-Ethyl-2-oxazoline)-poly(d,l-lactide)-poly(2-ethyl-2-oxazoline) Hydrogels.

Preparation, Characterization and Controlled Release Investigation of Interpenetrating Polymer Networks of Poly(acrylic Acid)/triazole Modified Poly(vinyl Alcohol).

Functionalized carbon nanostructures as temozolomide carriers; physicochemical and biopharmaceutical characterization

Physicochemical Characterization and Drug Release Properties of Pdmaema/Osa Semi-Ipn Hydrogels with Microporous Structure

Increased the TMZ concentration in brain by poly(2-ethyl-2-oxazoline) conjugated temozolomide prodrug micelles for glioblastoma treatment

Preparation and in Vitro Characterization of Paclitaxel-Loaded Ph-Responsive Polymeric Micelles Based on Poly(2-Ethyl-2-oxazoline)-vitamin E Succinate

Preparation, Characterization, and In Vitro Evaluation of Resveratrol-Loaded Cellulose Aerogel

Exploring temozolomide encapsulated PEGylated liposomes and lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and pharmacokinetic studies

Study on the gelation and sustained release effect of the thermosensitive material TPGS 1000

Poly(vinylcaprolactam)-Based Biodegradable Multiresponsive Microgels for Drug Delivery